Finally, murine histiocytic sarcomas could be induced using genetic lesions distinct from p16/p19−/−; Kras, i.e. MLL-AF9, thereby suggesting that the murine histiocytic induction model described here can be applied to study a broad spectrum of hematopoietic malignancies. Here, KRAS is linked to histiocytic sarcoma.